---
figid: PMC6071023__cancers-10-00224-g002
figtitle: Resistance to EGFR tyrosine kinase inhibitors
organisms:
- NA
pmcid: PMC6071023
filename: cancers-10-00224-g002.jpg
figlink: /pmc/articles/PMC6071023/figure/cancers-10-00224-f002/
number: F2
caption: EMT, MET amplification, and IGF-1R confer resistance to EGFR TKIs. Dimerization
  with IGF-1R allows activation of the MAPK and PI3K pathways despite EGFR inhibition.
  MET amplification allows phosphorylation of EGFR and activation of downstream signaling.
  Activation of the Hedgehog signaling pathway and Wnt signaling pathways promote
  EMT, which may confer resistance to EGFR TKIs.
papertitle: Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance.
reftext: Zachary Schrank, et al. Cancers (Basel). 2018 Jul;10(7):224.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.967272
figid_alias: PMC6071023__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6071023__F2
ndex: 3a0aa74f-decd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6071023__cancers-10-00224-g002.html
  '@type': Dataset
  description: EMT, MET amplification, and IGF-1R confer resistance to EGFR TKIs.
    Dimerization with IGF-1R allows activation of the MAPK and PI3K pathways despite
    EGFR inhibition. MET amplification allows phosphorylation of EGFR and activation
    of downstream signaling. Activation of the Hedgehog signaling pathway and Wnt
    signaling pathways promote EMT, which may confer resistance to EGFR TKIs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - WNT7B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - SMO
  - SMOX
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - NRAS
  - PTK2
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - TSC2
  - TSC1
  - CCL26
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ITK
  - SLC22A3
  - GATA6
  - RHEB
  - RHEBP1
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - Cancer
  - Cardiomyopathy
  - Lung cancer
---
